1.Clinical and Bacteriologic Characteristics of Retreated Tuberculosis Patients.
Seoung Joon OH ; Ki Heon YOON ; Jee Hong YOO ; Hong Mo KANG
Tuberculosis and Respiratory Diseases 1995;42(1):19-24
BACKGROUND: Although pulmonary tuberculosis is effectively controlled with 6 months or 9 months short course standard regimens, comparable numbers of treatment failures ensued because of inadequate treatment mainly due to patient's poor compliance. Indequate treatment with standard regimens during initial treatment may cause emergence of drug resistance and prolong the duration of chemotherapy. Also it may make the patient lesser compliant and finally increase the morbidity and the mortality. METHODS: A clinical study was done to evaluate clinical and bacteriological characteristics of 94 patients who were retreated for pulmonary tuberculosis. RESULTS: 1) 62 of the 94 patients were male and 32 patients were female. Mean age is 51 years old in male and 45 years old in female. 2) The extent of the disease on the chest radiograph was minimal in 10(11.1%) patients, moderate in 31(33.3%) patients, and far advanced in 52(55.6%) patients. 3) On sputum bacteriologic examination, 73(77.7%) patients were positive in sputum AFB smear and/or culture for Mycobacterium tuberculosis. 4) Results of drug sensitivity test performed in 42 patients showed that the resistance to one drug is in 9(20.5%) patients, two drugs in 18(40.8%) patients, and more than three drugs in 14(31.8%) patients. 5) Poor patient's compliance was the leading cause of the retreatment of pulmonary tuberculosis (43.6%) 6) Only 24(25.5%) patients of the 94 retreatment patients were successfully treated and 39 (41.6%) patients were dropped out during follow-up. CONCLUSION: We concluded that poor patient's compliance was the most important cause of treatment failure not only in primary treatment patients but also in retreatment patients. Primary treatment of pulmonary tuberculosis should be completed under strict monitoring of the patient because significant number of retreatment patients had multiple drug resistance and poor outcome.
Compliance
;
Drug Resistance
;
Drug Resistance, Multiple
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Mortality
;
Mycobacterium tuberculosis
;
Radiography, Thoracic
;
Retreatment
;
Sputum
;
Treatment Failure
;
Tuberculosis*
;
Tuberculosis, Pulmonary
2.Diagnostic and Therapeutic Problems of Pulmonary Tuberculosis in Elderly Patients.
Jae Ho LEE ; Dae Hee HAN ; Jae Woo SONG ; Hee Soon CHUNG
Journal of Korean Medical Science 2005;20(5):784-789
To identify differences in the clinical, radiologic, and microbiologic features of pulmonary tuberculosis (TB) in the young (<64 yr) and elderly (> or =65 yr), we performed a retrospective analysis of the medical charts and chest radiographs of 207 young and 119 elderly pulmonary TB patients. Hemoptysis and a febrile sense were more frequent in the young, whereas weakness, dyspnea, anorexia, and mental change were more frequent in the elderly. Elderly patients showed higher frequencies of cardiovascular and chronic lung diseases, whereas the young showed a higher proportion of underlying liver disease. In addition, chest radiography showed a significantly higher frequency of mid or lower lung involvement by TB lesions in the elderly (10.6% vs. 22.7%, p<0.05). Lesions were frequently misdiagnosed as pneumonia or lung cancer in the elderly. However, there was no difference between these two groups in terms of sputum acid-fast bacilli positivity. The elderly showed a higher frequency of adverse drug reactions (18.5% vs. 40.7%, p<0.05), and higher TB-related mortality (1.3% vs. 11.1%, p<0.05). In conclusion this study showed that young and elderly pulmonary TB patients have similar microbiologic features; however, the elderly showed higher frequencies of atypical clinical and radiologic presentations, adverse drug reactions, and higher TB-related mortality.
Adult
;
Aged
;
Aged, 80 and over
;
Antitubercular Agents/*therapeutic use
;
Comparative Study
;
Female
;
Humans
;
Incidence
;
Korea/epidemiology
;
Male
;
Middle Aged
;
Research Support, Non-U.S. Gov't
;
Retrospective Studies
;
Risk Assessment/*methods
;
Risk Factors
;
Survival Analysis
;
Survival Rate
;
Treatment Outcome
;
Tuberculosis, Pulmonary/*drug therapy/mortality/*radiography